Abstract

Major depressive disorder is often associated with deficits in social and cognitive functioning. Mice transgenic for acid sphingomyelinase (t-ASM) were previously shown to have a depressive-like phenotype, which could be normalized by antidepressant treatment. Here, we investigated whether t-ASM mice show deficits in social behavior and memory performance, and whether these possible deficits might be normalized by amitriptyline treatment. Our results revealed that ASM overexpression altered the behavior of mice in a sex-dependent manner. As such, t-ASM female, but not male, mice showed an impaired social preference and a depressive- and anxiogenic-like phenotype, which could be normalized by amitriptyline treatment. Both male and female t-ASM mice showed unaltered preference for social novelty, novel object recognition, and social and object discrimination abilities. Amitriptyline treatment impaired novel object recognition and object discrimination abilities in female, but not in male, wild-type mice, while female t-ASM mice showed unaltered novel object recognition and object discrimination abilities. This study suggests that female t-ASM mice represent a model of depression with comorbid anxiety and social deficits, without memory impairments. It further suggests that ASM overexpression has a protective role against the detrimental effects of amitriptyline on female, but not on male, non-social (object) memory.

Highlights

  • Major depressive disorder (MDD) is a severe and chronic mood disorder, with a lifetime prevalence of more than 10% [1]

  • This study demonstrates that acid sphingomyelinase (ASM) overexpression alters the behavior of mice in a sex-dependent manner

  • We could show that ASM overexpression impaired social preference and induced a depressive- and anxiogenic-like behavior in female, but not in male, mice without altering the preference for social novelty or social memory abilities in either sex

Read more

Summary

Introduction

Major depressive disorder (MDD) is a severe and chronic mood disorder, with a lifetime prevalence of more than 10% [1]. MDD is often associated with deficits in social functioning [2] and cognitive dysfunctions, such as memory impairment and concentration deficits [3]. Tricyclic antidepressant drugs, such as desipramine and imipramine, have been shown to induce the proteolytic degradation of the lysosomal glycoprotein acid sphingomyelinase (ASM) [4,5], an enzyme that catalyzes the hydrolysis of sphingomyelin into ceramide and phosphorylcholine [6], and thereby to functionally inhibit the activity of ASM [7]. PLOS ONE | DOI:10.1371/journal.pone.0162498 September 6, 2016

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.